KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Staar Surgical (STAA) Gross Margin (2016 - 2025)

Historic Gross Margin for Staar Surgical (STAA) over the last 16 years, with Q3 2025 value amounting to 82.21%.

  • Staar Surgical's Gross Margin rose 49000.0% to 82.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 73.87%, marking a year-over-year decrease of 48700.0%. This contributed to the annual value of 76.32% for FY2024, which is 20400.0% down from last year.
  • Latest data reveals that Staar Surgical reported Gross Margin of 82.21% as of Q3 2025, which was up 49000.0% from 74.0% recorded in Q2 2025.
  • Staar Surgical's 5-year Gross Margin high stood at 82.21% for Q3 2025, and its period low was 64.65% during Q4 2024.
  • For the 5-year period, Staar Surgical's Gross Margin averaged around 76.71%, with its median value being 77.84% (2022).
  • As far as peak fluctuations go, Staar Surgical's Gross Margin soared by 94800bps in 2021, and later plummeted by -149600bps in 2024.
  • Staar Surgical's Gross Margin (Quarter) stood at 76.25% in 2021, then grew by 2bps to 77.74% in 2022, then grew by 2bps to 79.62% in 2023, then decreased by -19bps to 64.65% in 2024, then increased by 27bps to 82.21% in 2025.
  • Its Gross Margin was 82.21% in Q3 2025, compared to 74.0% in Q2 2025 and 65.76% in Q1 2025.